Fas/CD95/Apo-I has been shown to stimulate a variety of molecules including several members of the caspase family and the acidic sphingomyelinase (Martin and Green 1995; Gulbins et al, 1995) . Here, we demonstrate that Fas receptortriggered activation of the acidic sphingomyelinase, consumption of sphingomyelin, release of ceramide, and subsequent activation of JNK and p38-K are regulated by caspases. Inhibition of caspases by Ac-YVAD-chloromethylketone or transient CrmA transfection prevented stimulation of acidic sphingomyelinase, release of ceramide and activation of JNK and p38-K upon Fas-receptor crosslinking. Likewise, Fas triggered apoptosis was almost completely blocked by Ac-YVAD-chloromethylketone or CrmA mediated inhibition of caspases. The results suggest a new signalling cascade from the Fas receptor via caspases to acidic sphingomyelinase, ceramide and JNK/p38-K.
Introduction
Apoptosis has been identified as an evolutionary conserved and fundamental active cellular mechanism occuring under a range of physiological and pathological conditions (Wyllie et al, 1980; Raff, 1992; Cohen, 1993) . Programmed cell death is characterized by distinct morphological changes of the cell including nuclear condensation and fragmentation, membrane blebbing and formation of apoptotic bodies (Kerr et al, 1972) . Several stimuli including the TNF-, NGF-, Fas/ApoI/ CD95-receptor, reactive oxygen intermediates (ROI), ionizing radiation, ceramides, heat shock, cytotoxic drugs, infection by some viruses or bacteria or withdrawal of growth factors induce apoptosis in different cell types (Beutler and Huffel, 1994; Bose et al, 1995; Collins, 1995; Hockenberry et al, 1993; Itoh et al, 1991; Obeid et al, 1993; Oehm et al, 1992; Smith et al, 1994; Stevenson et al, 1994; Verheij et al, 1996; Xia et al, 1995) .
The cellular homeostasis of the immune system is regulated by the balance between cell proliferation and programmed cell death. Apoptosis in mature lymphocytes can be induced by cellular stimulation via the Fas/ApoI/ CD95-receptor (Singer and Abbas, 1994) belonging to the family of the NGF/TNF-receptors, which are important in the regulation of apoptosis, proliferation or differentiation (Smith et al, 1994; Beutler and Huffel, 1994) . The major function of the Fas-receptor/Fas-ligand system seems to be the regulation of the peripheral immune response (Singer and Abbas, 1994; Nagata and Suda, 1995) . Thus, mutations of the Fas receptor or its ligand result in the defects of lpr and gld mice, respectively, characterized by lymphadenopathy, lymphoaccumulation and autoimmune organ failure (Watanabe-Fukunaga et al, 1992; Takahash et al, 1994; Wu et al, 1994) .
Several components of the death machinery have been identified. In particular, proteases of the caspase-family have been shown to be important in Fas-triggered apoptosis (Los et al, 1995; Enari et al, 1995) . Recently, it was demonstrated that the Fas receptor associates via its death domain, which exhibits significant homology with an intracellular domain of the TNF receptor and is required for induction of apoptosis (Tartaglia et al, 1993) , with FADD, TRADD or RIP (Chinnaiyan et al, 1995; Hsu et al, 1995; Stanger et al, 1995) . FADD in turn binds to caspase 8 (FLICE/MACH-1) (Boldin et al, 1996; Muzio et al, 1996) . Caspase 8 contains an ICE/Ced-3-like protease domain which seems to be activated upon ligation and trimerization of Fas by a conformational change of caspase 8 (Boldin et al, 1996; Muzio et al, 1996) . Caspase 8 then transmits the activation signal to other caspases, finally triggering cell death (Boldin et al, 1996; Muzio et al, 1996) . We and others have previously demonstrated that acidic sphingomyelinases and ceramide also play an important role for Fas induced apoptosis (Cifone et al, 1994; Tepper et al, 1995; Gulbins et al, 1995) . Ceramides are known stimuli of apoptosis and are released by activation of an acidic and/or neutral sphingomyelinase (Hannun, 1996) . Both enzymes have been shown to be activated by the Fas receptor (Cifone et al, 1995; Tepper et al, 1995; Gulbins et al, 1995) . The regulatory mechanisms of sphingomyelinase activation by the Fas receptor are completely unknown; however, recent data suggest that reaper triggered release of ceramide depends on the function of caspases (Pronk et al, 1996) , implying that sphingomyelinases and ceramide are downstream targets of caspases. Ceramide has been shown to stimulate a variety of enzymes including a phosphatase (Joseph et al, 1993) , a ceramide activated proline-directed protein kinase (Dobrowsky et al, 1993) , Jun-N-terminal kinase (Verheij et al, 1996; Westwick et al, 1995) , Raf-K (Huwiler et al, 1996) and tyrosine phosphorylation (Ji et al, 1995) .
Several other molecules have been shown to be involved in Fas-triggered apoptosis, in particular the small G-protein p21 Ras and inhibition of Ras blocks Fas-induced programmed cell death in Jurkat T cells (Gulbins et al, 1995) . Further molecules regulated upon Fas receptor triggering include phospholipase A 2 (Cifone et al, 1995) , NFkB (Ponton et al, 1996) , Jun-N-terminal Kinases (Latinis and Koretzky, 1996) , tyrosine and serine/threonine-kinases (Eischen et al, 1994; Schlottmann et al, 1996; Tian et al, 1995) , the tyrosine phosphatase FAP (Sato et al, 1995) , Rac-proteins or the K v 1.3 potassiumchannel .
To gain some insight into the molecular mechanisms of regulation of acidic sphingomyelinase, we investigated the effect of a pharmacological or CrmA mediated inhibition of caspases on acidic sphingomyelinase stimulation by Fas. The data provide evidence for a regulation of the acidic sphingomyelinase, consumption of sphingomyelin, release of ceramide and finally JNK/p38-K-activity by caspases, pointing to a novel signalling cascade important for Fasinduced apoptosis.
Results
Several results suggest a crucial function of caspases and the acidic sphingomyelinase releasing ceramide in apoptosis (Cifone et al, 1994; Gulbins et al, 1995; Tepper et al, 1995; Pronk et al, 1996) . The transient and early activation of some caspases by the Fas receptor as well as the involvement of caspases in reaper-mediated ceramide release points to a possible signalling function of caspases (Los et al, 1995; Enari et al, 1995; Pronk et al, 1996) in addition to being executors of cell death.
To test the hypothesis that caspases are involved in the regulation of ceramide release via stimulation of acidic sphingomyelinase, we used two inhibitors of caspases. The pharmacological peptide Ac-YVAD-chloromethylketone inhibits predominantly caspase-1 (Darmon et al, 1996) . Second, we transiently transfected a serpin like inhibitor of caspases, the viral gene CrmA, together with the B-cell surface antigen CD20 and sorted transfected cells via CD20. Similar to the pharmacological inhibitor, CrmA predominantly inactivates caspase-1, but at higher concentrations also caspase-3 (Nicholson et al, 1995; .
Treatment of Jurkat T cells with Ac-YVAD-chloromethylketone or CrmA prevented Fas induced cell death, showing the efficiency of caspase inhibition ( Figure 1 ). Next, we determined the consumption of sphingomyelin upon Fas receptor ligation in cells treated with Ac-YVAD-chloromethylketone, transfected with CrmA, or left untreated. The results show that pharmacological or CrmA mediated inhibition of caspases almost completely prevents sphingomyelin consumption after Fas receptor triggering in untreated cells (Figure 2a ). In addition, we directly inhibited acidic sphingomyelinase using the drug imipramine (40 mM). Imipramine induces degradation of the active 72 kDa isoform of the ASM by an unknown mechanism, whereas the inactive 75 kDa proform of the ASM is not affected by this drug (Hurwitz et al, 1994) . Efficient downregulation of the ASM upon incubation with imipramine was demonstrated by Western blotting of ASM immunoprecipitates from imipraminetreated or untreated Jurkat T cells (Figure 2b ). Shorter incubation with (less than 30 min) or lower doses (10 or 20 mM) of imipramine resulted in a partial reduction of acidic sphingomyelinase expression correlating with a partial inhibition of acidic sphingomyelinase activity and cell death (not shown).
Imipramine treated resulted in an almost complete abrogation of sphingomyelin consumption upon Fas ligation ( Figure 2a ). In accordance with the inhibition of sphingomyelin consumption, transfection with CrmA or treatment of the Jurkat cells with Ac-YVAD-chloromethylketone prevented the release of ceramide detected in normal, untreated Jurkat cells upon Fas receptor stimulation (Figure 3a and b). Ceramide release was also greatly reduced by preincubation of the cells with imipramine which directly blocks acidic sphingomyelinase (Figure 3a and b) .
Inhibition of sphingomyelin consumption and ceramide release by pharmacological or CrmA mediated blockade of caspases correlated with an almost complete prevention of Fas induced acidic sphingomyelinase activation ( Figure   Figure 1 Fas induced cell death is inhibited by transient transfection of CrmA or pharmacological inhibition of caspases. Jurkat cells were transiently transfected with CrmA or a control vector, labeled with [ 3 H]thymidine and stimulated via Fas. Alternatively, labeled cells were treated with 10 mM Ac-YVAD-chloromethylketone for 60 min prior to stimulation with anti-Fas. After 3 h incubation, cells were collected and DNA fragmentation determined by filtration through glass fiber filters and liquid scintillation counting. An aliquot of the cells was trypan blue stained and analyzed for typical morphological changes of apoptosis (Imi. = imipramine, ICE-Inh. = ICE-inhibitor, vector = vector control). Experiments were done in triplicate and repeated three times 4a), whereas untreated cells responded to anti-Fas with an approximately threefold stimulation of acidic sphingomyelinase activity. Acidic sphingomyelinase activity was directly measured by immunoprecipitation of acidic sphingomyelinase from stimulated or unstimulated cells and subsequent enzyme assay. Cells were either pretreated with the peptide Ac-YVAD-chloromethylketone blocking caspases or transfected with CrmA 36 h prior to the assay. Imipramine reduced acidic sphingomyelinase activity ( Figure 4 ) and protein levels by approximately 95% (Figure 2b) , however, the remaining 5% of acidic sphingomyelinase responded normally with a threefold stimulation of acidic sphingomyelinase activity. To further confirm that treatment of the cells with imipramine does not render the cells unresponsive to Fas-receptor ligation we determined the release of DAG upon Fas receptor ligation, which has been shown to be activated independently of the ASM after TNF receptor ligation (Schu È tze et al, 1992) . The results ( Figure 4b ) demonstrating a significant increase of DAG-release after Fas show that treatment of Jurkat cells with imipramine does not induce a general signalling block. This is also indicated by the finding that addition of 10 mM C6-ceramide to imipramine treated cells induced a similar rate of apoptosis as observed in cells not treated with imipramine (51+4% after 4 h in imipramine treated vs 53+6% in untreated cells).
A similar inhibition of Fas induced cell death and activation of the acidic sphingomyelinase was detected after incubation of Jurkat cells with 50 mM ZVAD-fmk (not shown) further supporting the notion of acidic sphingomyelinase regulation by caspases. The release of ceramide has been previously linked to the activation of JNK upon stimulation of cells via the Fas-or TNF-receptor or treatment with X-ray, UV-light or heat shock (Verheij et al, 1996) . We, therefore, tested, whether caspases are involved in the activation of JNK or p38-K by Fas ( Figure  5 ). JNK or p38-K activity was determined by incorporation of 32 P i in the substrate GST-c-Jun or GST-ATF-2, Acidic sphingomyelinase is synthesized in the cells as an inactive 75 kDa isoform which is then processed to the active 72 kDa isoform (Hurwitz et al, 1994; Lansmann et al, 1996) . The molecular details of this processing step are unknown. It is tempting to speculate that caspase-1 or other caspases cleave acidic sphingomyelinase and thus activate the enzyme. However, this hypothesis seems to be unlikely since known caspases are cytosolic whereas acidic sphingomyelinase resides in the endosomal/lysosomal compartiment. Therefore, an indirect mechanism involving further enzymes between caspases and acidic sphingomyelinase mediating the activation of acidic sphingomyelinase is more likely. Since proteins are usually unable to cross the lipid bilayer separating caspases and acidic sphingomyelinase, it seems possible that further lipid metabolites, which readily flip from one to the other compartiment, are released in the cytosol upon Fas receptor ligation and mediate the activation of the acidic sphingomyelinase.
CrmA and Ac-YVAD-chloromethylketone have been previously shown to inhibit members of the caspase family and to prevent Fas-induced apoptosis (Smith et al, 1996; pointing to the significance of this signalling pathway for Fas mediated apoptosis. CrmA predominantly inhibits caspase-1 and -8, however, at very high concentrations it also binds to and inhibits caspase-3 (Nicholson et al, 1995; Salvesen et al, 1997) . Similar to CrmA, the pharmacological inhibitor Ac-YVAD-chloromethylketone inhibits predominantly caspase-1, whereas several other caspases are almost unaffected by this peptide (Darmon et al, 1996) . Since caspase-8 seems to be one of the primary cellular targets of CrmA under physiological conditions (Zhou et al, 1997) and plays a major role in Fas triggered cell death (Boldin et al, 1996; Muzio et al, 1996) , this caspase is a good candidate for the protease involved in the regulation of acidic sphingomyelinase activation by Fas. However, the exact nature of the caspase involved in acidic sphingomyelinase activation has to be elucidated.
Our data suggest that caspase-1 itself or enzymes closely related to caspase-1 are (indirectly) mediating the activation of acidic sphingomyelinase upon Fas receptor ligation. It is unknown whether caspases are only executors of apoptosis or whether they also function as signalling molecules, however, our data indicate a signalling function of at least some caspases rather than being just executors of apoptosis. This notion is supported by several other studies: First, expression of the reaper protein, which is homologous to the cytoplasmic domain of Fas or TNF results in activation of caspases as well as in the formation of ceramide (Pronk et al, 1996) . Inhibition of caspases prevents reaper triggered ceramide release placing ceramide downstream of caspases (Pronk et al, 1996) . Ceramide, however, stimulates via a Bcl2 sensitive pathway other members of the caspase family, in particular caspase-3 (Smyth et al, 1996; Zhang et al, 1996) . Thus, (Smith et al, 1996) . However, these lymphocytes are still susceptible to X-irradiation induced apoptosis. Since X-rays induce an increase of ceramide concentration (Haimovitz-Friedman et al, 1994) , the results of these transgenic animals suggest that ceramide functions downstream of at least some caspases to mediate cell death. Third, it has been recently shown, that CrmA-, YVAD-cmk-or Z-VAD-fmk-mediated inhibition of caspases prevents Fas triggered p38-K activation (Juo et al, 1997) directly supporting the data of the present study. Further, Fas-receptor ligation has been shown to induce only a transient activation of caspases, peaking approximately already 20 min after stimulation via the Fas receptor (Los et al, 1995; Enari et al, 1995) . Thus, some caspases seem to be very early signalling molecules activated by the Fas receptor and might be upstream of the acidic sphingomyelinase. Finally, the release of ceramide upon ligation of the TNF receptor belonging to the same receptor family as Fas is inhibited by transfection of CrmA (Dbaibo et al, 1997) . This also suggests that some CrmA sensitive caspases are involved in the regulation of a sphingomyelinase.
Our notion of an activation of JNK and p38-K by Fas receptor ligation via stimulation of the acidic sphingomyelinase is supported by previous studies showing that Fas or ceramides stimulate JNK/p38-K (Verheij et al, 1996; Westwick et al, 1995; Latinis et al, 1996; Juo et al, 1997; Lenczowski et al, 1997) . Furthermore, ceramide-initiated JNK activation has been demonstrated to be essential for the induction of apoptosis after ionizing radiation, UV-light, heat shock, TNFa or H 2 O 2 (Verheij et al, 1996) , suggesting an important function of ceramide triggered activation of JNK for ceramide mediated programmed cell death. Fas belongs to a family of receptors including TNF, p75-NGF, OX-40, CD40 and some further molecules (Beutler and Huffel, 1994; Smith et al, 1994) . Apoptosis induced by p75-NGF receptor has been shown to involve activation of JNK/p38-K and inhibition of JNK/p38-K prevented cell death induced by NGF withdrawal from PC12-pheochromocytoma cells (Xia et al, 1995) . The activation of a similar signal transduction pathway has been reported to be stimulated by the TNF receptor (Verheij et al, 1996; Schu È tze et al, 1992; Trent et al, 1996) . These studies show a release of ceramide and an activation of Ras and JNK/p38-K after TNF receptor ligation which are critically involved in TNF-receptor mediated cell death (Verheij et al, 1996; Schu È tze et al, 1992; Trent et al, 1996) . Thus, TNF, p75-NGF and Fas seem to activate similar molecular mechanisms upon induction of apoptosis. However, a recent study using transfection of FADD, RIP or TRAF-2 into MCF-7 cells proposed that JNK-activation and apoptosis after TNF-receptor ligation are separate responses (Liu et al, 1996) . Therefore, JNK-activation may not be sufficient to trigger apoptosis by itself, however, under physiological conditions it might be necessary as a positive signal for other signals triggering programmed cell death. In situations with very high activation levels of the pathway triggering apoptosis, e.g. after transfection of genes inducing cell death, this positive feedback may not be absolutely required.
The results of the present study using imipramine point to an involvement of the acidic sphingomyelinase in Fas triggered death. However, since imipramine probably does not specifically inhibit the acidic sphingomyelinase, the exact function of this enzyme in Fas triggered cell death has to be elucidated using genetic approaches.
Taken together, the data suggest the following model: Fas activates some caspases (caspase 8 is a good candidate) which then stimulate directly or indirectly the acidic sphingomyelinase resulting in the release of ceramide. The activation of acidic sphingomyelinase and the release of ceramide seem to be crucial for Fas induced apoptosis since acidic sphingomyelinase deficient lymphocytes are resistant to Fas induced apoptosis (R. Kolesnick, personal communication). Ceramide may have multiple functions including the activation of JNK/p38-K as well as the stimulation of further members of the caspase family, e.g. caspase-3. These molecules then execute the apoptotic signal delivered by cellular stimulation via the Fas receptor (Figure 6 ).
Materials and Methods

Cell culture and stimulation
All reagents were purchased from Sigma, Deisenhofen, Germany, if not otherwise cited. Human Jurkat T cells were grown in RPMI-1640 medium supplemented with 10% fetal calf serum, 10 mM HEPES (pH 7.4), 2 mM L-glutamine, 1 mM sodium pyruvate, 100 mM non essential amino acids, 100 units/ml penicillin, 100 mg/ml streptomycin and 50 mM b-mercaptoethanol (all from Gibco-BRL, Eggenstein, Germany). For activation, cells were washed twice in HEPES buffered saline (H/S, 132 mM NaCl, 20 mM HEPES, 5 mM KCl, 1 mM CaCl 2 , 0.7 mM MgCl 2 , 0.8 mM MgSO 4 ) and incubated at 378C with 2 mg/ml monoclonal anti-human-Fas-antibody (clone CH-11; Dianova-Immunotech, Hamburg, Germany) for the indicated times.
Inhibition of caspases and acidic sphingomyelinase
Co-transfection of Jurkat cells with 40 mg each SRSa-crmA or vector control (SRSa) with an expression vector for CD20 (pRc/CMV-cd20) (10 mg) was performed as previously described (10). Briefly, cells were electroporated using a BTX-electroporator at five pulses (99 msec) and 500 V. Twelve hours later viable cells were purified by Ficoll gradient centrifugation and cultured for an additional 24 h. CD20 + cells were then selected by incubation with 50 mg/ml anti-CD20 mAb (Dianova) (60 min, 48C), three times washing and further incubation (60 min, 48C) with magnetic beads coated with a sheep anti-mouse Immunoglobulin (Dynal, Hamburg, Germany) (Gulbins et al, 1995) . Since the ratio of 5 : 1 SRSa-crmA : pRc/CMV-cd20 drives expression of CrmA in any CD20 + cell, the selection of CD20 + cells permits effective sorting for CrmA expressing cells. The fraction of CD20-positive and thus CrmA transfected cells was determined by in vivo labeling of the cells with [ 3 H]thymidine as previously described (Gulbins et al, 1995) . Aliquots of labeled cells were counted prior and after sorting via magnetic beads. These experiments showed that approximately 10% of all cells were CD20-positive. Non-specific binding of the cells to the magnetic beads did not excede 0.5% of all cells as determined by incubation of cells with an irrelevant monoclonal mouse antibody (50 mg) and magnetic beads. Purified cells were allowed to recover for 30 min at 378C and then used for biological assays or determination of apoptosis.
Alternatively, caspases were inhibited by 60 min preincubation with 10 mM of the irreversible pharmacological inhibitor Ac-YVADchloromethylketone (Bachem, Hannover, Germany). Acidic sphingomyelinase was inhibited by 60 min preincubation of the cells with 40 mM imipramine in RPMI/1640 supplemented with 0.5% BSA, 10 mM HEPES (pH 7.4), 2 mM L-glutamine, 1 mM sodium pyruvate and 100 mM non essential amino acids.
Measurement of sphingomyelin consumption
Cells were metabolically labeled by incubation with 1 mCi/ml [methyl-3 H]choline chloride (60 ± 90 Ci/mmol; NEN-DuPont, BadHomburg, Germany) for 48 h in complete RPMI-medium. Cells were washed three times and stimulated via Fas for the indicated time. Infection was terminated by extraction in 120 ml 0.22 M HCl, 2.7 ml CHCl 3 : CH 3 OH (2 : 1, v/v), 0.9 ml of CHCl 3 and 0.9 ml of 1 M KCl. The organic phase was collected after mixing and centrifugation for 15 min at 8006g, dried, resuspended in CHCl 3 : CH 3 OH (1 : 1, v/v) and lipids were separated on G60 silica gel thin layer chromatography plates (MacheryNagel, Dueren, Germany) using CHCl 3 : CH 3 OH : H 2 O : acetic acid (50 : 30 : 8 : 4, v/v/v/v) as solvent system. Sphingomyelin was identified by co-migration with standards, scrapped from the plate and radioactivity in each spot determined by liquid scintillation counting.
Activity of acidic sphingomyelinase
The activity of acidic sphingomyelinase upon Fas receptor ligation was measured by an immunoprecipitation technique. Stimulated or unstimulated cells were lysed in ice-cold 50 mM Tris (pH 7.4), 10 mM Bacitracin, 1 mM Benzamidine, 10 mM Na 3 VO 4 , 10 mg/ml of each aprotinin and leupeptin, 0.1 mg/ml soybean trypsin inhibitor and 0.2% Triton X-100 and immediately sonicated for 10 s. Sonication was repeated three times and insoluble cell debris pelleted by 5 min centrifugation at 6006g. An equal amount of 50 mM Tris (pH 7.4), 3% NP40, 1% Triton X-100, 10 mM Na 3 VO 4 , 100 mg/ml each aprotinin and leupeptin (lysis buffer) was added to the samples and ASM was immunoprecipitated from the supernatants using a goat anti-ASMantiserum previously characterised (Hurwitz et al, 1994) . Samples were incubated for 4 h at 48C, immunocomplexes were immobilized by addition of 20 ml protein A/G coupled agarose (Santa Cruz Inc, Santa Cruz, CA), and further incubation for 60 min at 48C. The immunoprecipitates were washed three times in lysis buffer, followed by additional three washes in 50 mM sodium acetate (pH 5.0), 0.2% Triton X-100, 1 mM Na 3 VO 4 and 10 mg/ml each aprotinin and leupeptin. Washed immunoprecipitates were incubated with [ 14 C]sphingomyelin (0.5 mCi/sample, 54.5 mCi/mmol; NEN-DuPont) in 250 mM sodium acetate (pH 5.0), 1.3 mM EDTA, 0.05% NP40 (assay buffer) at 378C for 30 min. The substrate [ 14 C]sphingomyelin was solubilized after drying by 10 min bath sonication in assay buffer. Assays were terminated by extraction with 800 ml Chloroform : Methanol (2 : 1, v/v) and 250 ml H 2 O. The upper phase was collected and radioactivity reflecting the degradation of [ 14 C]sphingomyelin was determined by liquid scintillation counting.
Determination of diacylglycerol and ceramide
For determination of ceramide, cells were stimulated with anti-Fas antibodies for the indicated time, washed and extracted with CHl 3 : CH 3 OH : HCl (100 : 100 : 1, v/v/v). Aliquots of the organic phase were dried under vacuum, DAG was digested by mild alkaline hydrolysis in 0.1 M methanolic KCl, the samples were reextracted as above, dried and solubilized by 10 min bath sonication in 7.5% (w/v) noctyl-b-glucopyranoside, 5 mM cardiolipin, 1 mM diethylenetriaminepentaacetic acid (DETAPAC). After sonication 40 mg/ml of purified E. coli DAG-kinase (Amersham, Braunschweig, Germany) in 70 ml reaction buffer (100 mM imidazole-HCl (pH 6.6), 100 mM NaCl, 25 mM MgCl 2 and 2 mM EGTA) supplemented with 10 mCi/sample [ 32 P]gATP and 1 mM ATP were added and the samples were incubated at 228C for 30 min. The kinase reaction was stopped by addition of 1 ml CHCl 3 : CH 3 OH : HCl (100 : 100 : 1, v/v/v), 170 ml of salt solution (10 mM HEPES (pH 7.2), 135 mM NaCl, 1.5 mM CaCl 2 , 0.5 mM MgCl 2 and 5.6 mM glucose) and 30 ml of 100 mM EDTA. The lower organic phase was dried, resuspended in CHCl 3 : CH 3 OH (1 : 1, v/v) and resolved by TLC using CHCl 3 : CH 3 OH : acetic acid (65 : 15 : 5, v/v/v) as solvent. Spots were visualized by autoradiography, scrapped from the plate and analyzed by liquid scintillation counting. The ceramide content of the samples was determined by comparison with a standard curve containing known quantities of ceramide.
The release of DAG was determined by the same protocol with omission of the mild alkaline hydrolysis in 0.1 M methanolic KCl.
JNK-and p38-K-activity
To measure the activity of JNK or p38-K, cells were lysed in 25 mM HEPES (pH 7.4), 0.2% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 125 mM NaCl, 10 mM each NaF, Na 3 VO 4 and sodium pyrophosphate and 10 mg/ml of each aprotinin and leupeptin (RIPAbuffer) after stimulation via Fas. Lysates were centrifuged at 25 0006g for 20 min and JNK or p38-K immunoprecipitated from the supernatants at 48C for 4 h using polyclonal rabbit anti-human JNK-or p38-K-antiserum (Santa Cruz Inc.). Immunocomplexes were immobilized on agarose-coupled protein A/G, incubated for additional 60 min at 48C, washed twice in RIPA-buffer, twice in H/S, 1% NP-40, 2 mM Na 3 VO 4 , once in 100 mM TrisHCl (pH 7.5), 0.5 M LiCl and finally twice in kinase buffer 12.5 mM MOPS (pH 7.5), 12.5 mM bglycerophosphate, 7.5 mM MgCl 2 and 0.5 mM of each NaF, EGTA and Na 3 VO 4 . After washing, the immunoprecipitates were resuspended in kinase buffer supplemented with 10 mCi/sample [ 32 P]gATP (6000 Ci/ mmol, NEN/DuPont), 10 mM ATP and 1 mg/ml GST-c-Jun (aminoacids 1 ± 79) or GST-ATF-2 (aminoacids 1 ± 96). The samples were incubated at 308C for 15 min and stopped by addition of 5 ml boiling 56 reducing SDS-sample buffer. Samples were separated by 10% SDS ± PAGE and analyzed by autoradiography. The substrates GSTc-Jun or GST-ATF-2 were expressed in DH5a-bacteria after transformation, growth for 12 h and incubation with IPTG (200 mM) for 4 h. Bacteria were lysed in 25 mM HEPES (pH 7.4), 0.2% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 125 mM NaCl and 10 mg/ml of each aprotinin and leupeptin; GST-fusion proteins were purified by binding to glutathione agarose and eluted in kinase buffer with 20 mM glutathione. Purity of the preparations was tested by SDS ± PAGE and Coomassie staining.
Apoptosis
Fas-induced cell death was determined by metabolic labeling of CrmAtransfected or untransfected Jurkat cells for 12 h with 10 mCi/ml [ 3 H]thymidine (8.3 Ci/mmol; NEN/DuPont) (Gulbins et al, 1995) . Cells were washed, aliquoted, pretreated with Ac-YVAD-chloromethylketone or imipramine and incubated with anti-Fas (200 ng/ml) or left untreated. Cell death was determined after 3 h by DNA fragmentation and trypan blue staining. Briefly, cells were disrupted by one cycle of freezing at 7208C and thawing, unfragmented genomic DNA was collected by filtration through glass fiber filters (Pharmacia, Freiburg, Germany) and counted by liquid scintillation (Gulbins et al, 1995) . Results are expressed as % DNA fragmentation+s.d. compared with control samples. Experiments were done in triplicates and repeated three times. In all experiments an aliquot of the cells was analyzed for cell death by trypan blue. Apoptosis was further identified by typical morphological changes, in particular membrane blebbing, condensation and fragmentation of nuclei. Comparison of the DNA fragmentation method with morphologic changes permits exact determination of apoptosis vs necrosis. In all experiments apoptosis in untreated cells did not excede 5% of all cells.
